COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Esophageal and Gastric Diseases With Robotically Controlled Magnetic Capsule Endoscopy (MACEOES)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04068480
Recruitment Status : Recruiting
First Posted : August 28, 2019
Last Update Posted : August 30, 2019
Information provided by (Responsible Party):
László Madácsy Md, PhD, Bács-Kiskun County Teaching Hospital

Brief Summary:
Magnetically assisted capsule endoscopy (MACE) is a novel tool to examine the upper GI tract. The position of these new method in the examination of esophagus and stomach disorders is not clear until now.

Condition or disease
Video Capsule Endoscopy

Detailed Description:

Magnetic capsule endoscopy (MACE) systems were developed over the past 5-10 years to investigate the upper GI tract, especially the stomach. The new Navicam MACE system is composed of a magnetic capsule endoscope, an external controller magnet, a data recording set and a computing workstation, and with the aid of the appropriate software a real time follow up and controlling of the magnetic capsule inside the body is possible. This methodology could be an optimal non-invasive method of choice for gastric cancer and Barrett esophagus screening in high risk population in the near future.

Esophagogastroduodenoscopy (EGD) is the gold standard diagnostic test, however it is very uncomfortable for patients without sedation.

The aim of our present study was a feasibility study to assess the safety and efficacy of Ankon MACE to investigate gastric and esophageal disorders in patients referred to small bowel capsule endoscopy investigations into our endoscopy and to develop and test a method with MACE for esophageal investigation and to analyse the visualisation of stomach mucose with automatic and manual capsule maneuvering.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 300 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Study of Esophageal and Gastric Diseases With Robotically Controlled Magnetic Capsule Endoscopy
Actual Study Start Date : November 15, 2017
Estimated Primary Completion Date : December 31, 2020
Estimated Study Completion Date : January 31, 2021

Resource links provided by the National Library of Medicine

Capsule endoscopy
Patient refered for small bowel capsule endoscopy in conventional indication.

Primary Outcome Measures :
  1. Reflux esophagitis [ Time Frame: 1 year ]
    Proportion and the severity of reflux (Los Angeles classification) comparing to gastroscopy

  2. Diseases [ Time Frame: 1 year ]
    Proportion of other disorders of oesophagus and stomach comparing to gastroscopy

  3. Stomach examination [ Time Frame: 1 year ]
    Analyze the visualisation of gastric mucosa with MACE system

Secondary Outcome Measures :
  1. Restrain time [ Time Frame: 1 year ]
    Analysing the correlation with MACE system between esophageal restrain time and diagnostic yield

  2. Cleaning [ Time Frame: 1 year ]
    Analysis of stomach preparation with a special software concerning the percentage of clean and covered areas.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Every patient how met the eligibility criteria and had MACE examination with oesophageal protocol

Inclusion Criteria:

- patient refered for small bowel capsule endoscopy in any indication

Exclusion Criteria:

  • known or suspected stricture in the GI tract
  • previous surgery with bowel anastomosis
  • swallowing complaints
  • dementia
  • implanted cardioverter defibrillator
  • implanted

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT04068480

Layout table for location contacts
Contact: Milan Szalai, M.D. 0036203777818

Layout table for location information
Endo-Kapszula Privat Medical Cenbter Recruiting
Székesfehérvár, Hungary, 8000
Contact: Milan Szalai, M.D.    +36203777818   
Sponsors and Collaborators
Bács-Kiskun County Teaching Hospital
Layout table for investigator information
Principal Investigator: László Madácsy, Prof. Bács-Kiskun County Teaching Hospital
Layout table for additonal information
Responsible Party: László Madácsy Md, PhD, Clinical Professor, Bács-Kiskun County Teaching Hospital Identifier: NCT04068480    
Other Study ID Numbers: BacsKiskunCTH
First Posted: August 28, 2019    Key Record Dates
Last Update Posted: August 30, 2019
Last Verified: August 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: No
Keywords provided by László Madácsy Md, PhD, Bács-Kiskun County Teaching Hospital:
capsule endoscopy
magnetically assisted capsule endoscopy
Additional relevant MeSH terms:
Layout table for MeSH terms
Stomach Diseases
Gastrointestinal Diseases
Digestive System Diseases